Oral topotecan is well tolerated as second-line therapy for ovarian cancer

Autor:	Howard Hochster
Rok vydání:	2002
Předmět:	Oncology Second-line therapy medicine.medical_specialty business.industry Internal medicine medicine Topotecan Ovarian cancer medicine.disease business medicine.drug
Zdroj:	Evidence-based Oncology. 3:120-122
ISSN:	1363-4054
DOI:	10.1054/ebon.2002.0026
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cf54ede971d59e8a1262f2845aaeddb9 https://doi.org/10.1054/ebon.2002.0026 Zobrazit plný text záznamu Full Text from ScienceDirect